microRNAs: critical targets for treating rheumatoid arthritis angiogenesis

References

• Leblond A, Allanore Y, Avouac J. Targeting synovial neoangiogenesis in rheumatoid arthritis. Autoimmun Rev. 2017;16(6):594–601. doi:10.1016/j.autrev.2017.04.005.
   PubMed Web of Science ®Google Scholar
• Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023–2038. doi:10.1016/S0140-6736(16)30173-8.
   PubMed Web of Science ®Google Scholar
• McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205–2219. doi:10.1056/NEJMra1004965.
   PubMed Web of Science ®Google Scholar
• Feng ZT, Yang T, Hou XQ, et al. Sinomenine mitigates collagen-induced arthritis mice by inhibiting angiogenesis. Biomed Pharmacother. 2019;113:108759. doi:10.1016/j.biopha.2019.108759.
   PubMed Web of Science ®Google Scholar
• Zhai KF, Duan H, Khan GJ, et al. Salicin from Alangium chinense ameliorates rheumatoid arthritis by modulating the Nrf2–HO-1–ROS pathways. J Agric Food Chem. 2018;66(24):6073–6082. doi:10.1021/acs.jafc.8b02241.
   PubMed Web of Science ®Google Scholar
• Zhai KF, Duan H, Chen Y, et al. Apoptosis effects of imperatorin on synoviocytes in rheumatoid arthritis through mitochondrial/caspase-mediated pathways. Food Funct. 2018;9(4):2070–2079. doi:10.1039/c7fo01748k.
   PubMed Web of Science ®Google Scholar
• Ramjiawan RR, Griffioen AW, Duda DG. Anti-angiogenesis for cancer revisited: is there a role for combinations with immunotherapy? Angiogenesis. 2017;20(2):185–204. doi:10.1007/s10456-017-9552-y.
   PubMed Web of Science ®Google Scholar
• Elshabrawy HA, Chen Z, Volin MV, et al. The pathogenic role of angiogenesis in rheumatoid arthritis. Angiogenesis. 2015;18(4):433–448. doi:10.1007/s10456-015-9477-2.
   PubMed Web of Science ®Google Scholar
• Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120(1):15–20. doi:10.1016/j.cell.2004.12.035.
   PubMed Web of Science ®Google Scholar
• Orso F, Quirico L, Dettori D, et al. Role of miRNAs in tumor and endothelial cell interactions during tumor progression. Semin Cancer Biol. 2020;60:214–224. doi:10.1016/j.semcancer.2019.07.024.
   PubMed Web of Science ®Google Scholar
• Soufi-Zomorrod M, Hajifathali A, Kouhkan F, et al. microRNAs modulating angiogenesis: miR-129-1 and miR-133 act as angio-miR in HUVECs. Tumour Biol. 2016;37(7):9527–9534. doi:10.1007/s13277-016-4845-0.
   PubMedGoogle Scholar
• Leone P, Buonavoglia A, Fasano R, et al. Insights into the regulation of tumor angiogenesis by micro-RNAs. J Clin Med. 2019;8(12):2030.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang L, Chen C, et al. New insights into the regulatory role of microRNA in tumor angiogenesis and clinical implications. Mol Cancer. 2018;17(1):22. doi:10.1186/s12943-018-0766-4.
   PubMedGoogle Scholar
• Gregory RI, Yan KP, Amuthan G, et al. The microprocessor complex mediates the genesis of microRNAs. Nature. 2004;432(7014):235–240. doi:10.1038/nature03120.
   PubMed Web of Science ®Google Scholar
• Han J, Lee Y, Yeom KH, et al. The Drosha–DGCR8 complex in primary microRNA processing. Genes Dev. 2004;18(24):3016–3027. doi:10.1101/gad.1262504.
   PubMed Web of Science ®Google Scholar
• Saliminejad K, Khorram KH, Soleymani FS, et al. An overview of microRNAs: biology, functions, therapeutics, and analysis methods. J Cell Physiol. 2019;234(5):5451–5465. doi:10.1002/jcp.27486.
   PubMed Web of Science ®Google Scholar
• Gregory RI, Chendrimada TP, Cooch N, et al. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell. 2005;123(4):631–640. doi:10.1016/j.cell.2005.10.022.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Tomari Y. RISC assembly: coordination between small RNAs and argonaute proteins. Biochim Biophys Acta. 2016;1859(1):71–81. doi:10.1016/j.bbagrm.2015.08.007.
   PubMed Web of Science ®Google Scholar
• Matsuyama H, Suzuki HI. Systems and synthetic microRNA biology: from biogenesis to disease pathogenesis. Int J Mol Sci. 2019;21(1):132.
   PubMed Web of Science ®Google Scholar
• Kondo N, Kuroda T, Kobayashi D. Cytokine networks in the pathogenesis of rheumatoid arthritis. Int J Mol Sci. 2021;22(20):10922.
   PubMed Web of Science ®Google Scholar
• Lin YJ, Anzaghe M, Schülke S. Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis. Cells. 2020;9(4):880. doi:10.3390/cells9040880.
   PubMed Web of Science ®Google Scholar
• Jang S, Kwon EJ, Lee JJ. Rheumatoid arthritis: pathogenic roles of diverse immune cells. Int J Mol Sci. 2022;23(2):905.
   PubMed Web of Science ®Google Scholar
• Chen Z, Bozec A, Ramming A, et al. Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis. Nat Rev Rheumatol. 2019;15(1):9–17. doi:10.1038/s41584-018-0109-2.
   PubMed Web of Science ®Google Scholar
• Tu J, Hong W, Zhang P, et al. Ontology and function of fibroblast-like and macrophage-like synoviocytes: how do they talk to each other and can they be targeted for rheumatoid arthritis therapy? Front Immunol. 2018;9:1467. doi:10.3389/fimmu.2018.01467.
   PubMed Web of Science ®Google Scholar
• Pap T, Meinecke I, Müller-Ladner U, et al. Are fibroblasts involved in joint destruction? Ann Rheum Dis. 2005;64(Suppl. 4):iv52–iv54. doi:10.1136/ard.2005.042424.
   PubMedGoogle Scholar
• Nygaard G, Firestein GS. Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes. Nat Rev Rheumatol. 2020;16(6):316–333. doi:10.1038/s41584-020-0413-5.
   PubMed Web of Science ®Google Scholar
• Tsaltskan V, Firestein GS. Targeting fibroblast-like synoviocytes in rheumatoid arthritis. Curr Opin Pharmacol. 2022;67:102304. doi:10.1016/j.coph.2022.102304.
   PubMed Web of Science ®Google Scholar
• Masoumi M, Bashiri H, Khorramdelazad H, et al. Destructive roles of fibroblast-like synoviocytes in chronic inflammation and joint damage in rheumatoid arthritis. Inflammation. 2021;44(2):466–479. doi:10.1007/s10753-020-01371-1.
   PubMed Web of Science ®Google Scholar
• Mohr T, Haudek-Prinz V, Slany A, et al. Proteome profiling in IL-1β and VEGF-activated human umbilical vein endothelial cells delineates the interlink between inflammation and angiogenesis. PLOS One. 2017;12(6):e179065. doi:10.1371/journal.pone.0179065.
   Web of Science ®Google Scholar
• Cutolo M, Campitiello R, Gotelli E, et al. The role of M1/M2 macrophage polarization in rheumatoid arthritis synovitis. Front Immunol. 2022;13:867260. doi:10.3389/fimmu.2022.867260.
   PubMed Web of Science ®Google Scholar
• Elemam NM, Hannawi S, Maghazachi AA. Role of chemokines and chemokine receptors in rheumatoid arthritis. Immunotargets Ther. 2020;9:43–56. doi:10.2147/ITT.S243636.
   PubMed Web of Science ®Google Scholar
• Ross EA, Devitt A, Johnson JR. Macrophages: the good, the bad, and the gluttony. Front Immunol. 2021;12:708186. doi:10.3389/fimmu.2021.708186.
   PubMed Web of Science ®Google Scholar
• Szekanecz Z, Koch AE. Chemokines and angiogenesis. Curr Opin Rheumatol. 2001;13(3):202–208. doi:10.1097/00002281-200105000-00009.
   PubMed Web of Science ®Google Scholar
• Pickens SR, Volin MV, Mandelin AN, et al. IL-17 contributes to angiogenesis in rheumatoid arthritis. J Immunol. 2010;184(6):3233–3241. doi:10.4049/jimmunol.0903271.
   PubMed Web of Science ®Google Scholar
• George G, Shyni GL, Raghu KG. Current and novel therapeutic targets in the treatment of rheumatoid arthritis. Inflammopharmacology. 2020;28(6):1457–1476. doi:10.1007/s10787-020-00757-9.
   PubMed Web of Science ®Google Scholar
• Guo X, Chen G. Hypoxia-inducible factor is critical for pathogenesis and regulation of immune cell functions in rheumatoid arthritis. Front Immunol. 2020;11:1668. doi:10.3389/fimmu.2020.01668.
   PubMed Web of Science ®Google Scholar
• Gong Y, Yu Z, Wang Y, et al. Effect of moxibustion on HIF-1α and VEGF levels in patients with rheumatoid arthritis. Pain Res Manag. 2019;2019:4705247. doi:10.1155/2019/4705247.
   PubMed Web of Science ®Google Scholar
• Le QT, Fisher R, Oliner KS, et al. Prognostic and predictive significance of plasma HGF and IL-8 in a phase III trial of chemoradiation with or without tirapazamine in locoregionally advanced head and neck cancer. Clin Cancer Res. 2012;18(6):1798–1807. doi:10.1158/1078-0432.CCR-11-2094.
   PubMed Web of Science ®Google Scholar
• Hu F, Mu R, Zhu J, et al. Hypoxia and hypoxia-inducible factor-1α provoke Toll-like receptor signalling-induced inflammation in rheumatoid arthritis. Ann Rheum Dis. 2014;73(5):928–936. doi:10.1136/annrheumdis-2012-202444.
   PubMed Web of Science ®Google Scholar
• McGarry T, Hanlon MM, Marzaioli V, et al. Rheumatoid arthritis CD14(+) monocytes display metabolic and inflammatory dysfunction, a phenotype that precedes clinical manifestation of disease. Clin Transl Immunol. 2021;10(1):e1237.
   PubMed Web of Science ®Google Scholar
• Lee P, Chandel NS, Simon MC. Cellular adaptation to hypoxia through hypoxia inducible factors and beyond. Nat Rev Mol Cell Biol. 2020;21(5):268–283. doi:10.1038/s41580-020-0227-y.
   PubMed Web of Science ®Google Scholar
• Tannahill GM, Curtis AM, Adamik J, et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature. 2013;496(7444):238–242. doi:10.1038/nature11986.
   PubMed Web of Science ®Google Scholar
• Li Y, Liu Y, Wang C, et al. Succinate induces synovial angiogenesis in rheumatoid arthritis through metabolic remodeling and HIF-1α/VEGF axis. Free Radic Biol Med. 2018;126:1–14. doi:10.1016/j.freeradbiomed.2018.07.009.
   PubMed Web of Science ®Google Scholar
• Haas R, Smith J, Rocher-Ros V, et al. Lactate regulates metabolic and pro-inflammatory circuits in control of T cell migration and effector functions. PLoS Biol. 2015;13(7):e1002202. doi:10.1371/journal.pbio.1002202.
   PubMed Web of Science ®Google Scholar
• Johnson MO, Wolf MM, Madden MZ, et al. Distinct regulation of Th17 and Th1 cell differentiation by glutaminase-dependent metabolism. Cell. 2018;175(7):1780–1795.e19. doi:10.1016/j.cell.2018.10.001.
   PubMed Web of Science ®Google Scholar
• Asquith DL, Ballantine LE, Nijjar JS, et al. The liver X receptor pathway is highly upregulated in rheumatoid arthritis synovial macrophages and potentiates TLR-driven cytokine release. Ann Rheum Dis. 2013;72(12):2024–2031. doi:10.1136/annrheumdis-2012-202872.
   PubMed Web of Science ®Google Scholar
• Alles J, Fehlmann T, Fischer U, et al. An estimate of the total number of true human miRNAs. Nucleic Acids Res. 2019;47(7):3353–3364. doi:10.1093/nar/gkz097.
   PubMed Web of Science ®Google Scholar
• Sun LL, Li WD, Lei FR, et al. The regulatory role of microRNAs in angiogenesis-related diseases. J Cell Mol Med. 2018;22(10):4568–4587. doi:10.1111/jcmm.13700.
   PubMed Web of Science ®Google Scholar
• Poliseno L, Tuccoli A, Mariani L, et al. microRNAs modulate the angiogenic properties of HUVECs. Blood. 2006;108(9):3068–3071. doi:10.1182/blood-2006-01-012369.
   PubMed Web of Science ®Google Scholar
• Kuehbacher A, Urbich C, Zeiher AM, et al. Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ Res. 2007;101(1):59–68. doi:10.1161/CIRCRESAHA.107.153916.
   PubMed Web of Science ®Google Scholar
• Gao S, Gao H, Dai L, et al. miR-126 regulates angiogenesis in myocardial ischemia by targeting HIF-1α. Exp Cell Res. 2021;409(2):112925. doi:10.1016/j.yexcr.2021.112925.
   PubMed Web of Science ®Google Scholar
• Ebrahimi F, Gopalan V, Smith RA, et al. miR-126 in human cancers: clinical roles and current perspectives. Exp Mol Pathol. 2014;96(1):98–107. doi:10.1016/j.yexmp.2013.12.004.
   PubMed Web of Science ®Google Scholar
• Nicoli S, Knyphausen CP, Zhu LJ, et al. miR-221 is required for endothelial tip cell behaviors during vascular development. Dev Cell. 2012;22(2):418–429. doi:10.1016/j.devcel.2012.01.008.
   PubMed Web of Science ®Google Scholar
• Chang TK, Zhong YH, Liu SC, et al. Apelin promotes endothelial progenitor cell angiogenesis in rheumatoid arthritis disease via the miR-525-5p/angiopoietin-1 pathway. Front Immunol. 2021;12:737990. doi:10.3389/fimmu.2021.737990.
   PubMed Web of Science ®Google Scholar
• Chen Y, Dang J, Lin X, et al. RA fibroblast-like synoviocytes derived extracellular vesicles promote angiogenesis by miRNA-1972 targeting p53/mTOR signaling in vascular endotheliocyte. Front Immunol. 2022;13:793855. doi:10.3389/fimmu.2022.793855.
   PubMed Web of Science ®Google Scholar
• Chen CY, Su CM, Hsu CJ, et al. Ccn1 promotes VEGF production in osteoblasts and induces endothelial progenitor cell angiogenesis by inhibiting miR-126 expression in rheumatoid arthritis. J Bone Miner Res. 2017;32(1):34–45. doi:10.1002/jbmr.2926.
   PubMed Web of Science ®Google Scholar
• Chen Z, Wang H, Xia Y, et al. Therapeutic potential of mesenchymal cell-derived miRNA-150-5p-expressing exosomes in rheumatoid arthritis mediated by the modulation of MMP14 and VEGF. J Immunol. 2018;201(8):2472–2482. doi:10.4049/jimmunol.1800304.
   PubMed Web of Science ®Google Scholar
• Huang CC, Law YY, Liu SC, et al. Adiponectin promotes VEGF expression in rheumatoid arthritis synovial fibroblasts and induces endothelial progenitor cell angiogenesis by inhibiting miR-106a-5p. Cells. 2021;10(10):2627. doi:10.3390/cells10102627.
   PubMed Web of Science ®Google Scholar
• Huang CC, Tseng TT, Liu SC, et al. S1P increases VEGF production in osteoblasts and facilitates endothelial progenitor cell angiogenesis by inhibiting miR-16-5p expression via the c-Src/FAK signaling pathway in rheumatoid arthritis. Cells. 2021;10(8):2168. doi:10.3390/cells10082168.
   PubMed Web of Science ®Google Scholar
• Li TM, Liu SC, Huang YH, et al. YKL-40-induced inhibition of miR-590-3p promotes interleukin-18 expression and angiogenesis of endothelial progenitor cells. Int J Mol Sci. 2017;18(5):920.
   PubMed Web of Science ®Google Scholar
• Su CM, Hsu CJ, Tsai CH, et al. Resistin promotes angiogenesis in endothelial progenitor cells through inhibition of microRNA206: potential implications for rheumatoid arthritis. Stem Cells. 2015;33(7):2243–2255. doi:10.1002/stem.2024.
   PubMed Web of Science ®Google Scholar
• Zhang J, Ma Y, Zhang Y, et al. Angiogenesis is inhibited by arsenic trioxide through downregulation of the circHIPK3/miR-149-5p/FOXO1/VEGF functional module in rheumatoid arthritis. Front Pharmacol. 2021;12:751667. doi:10.3389/fphar.2021.751667.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang Y, Ma Y, et al. Therapeutic potential of exosomal circRNA derived from synovial mesenchymal cells via targeting circEDIL3/miR-485-3p/PIAS3/STAT3/VEGF functional module in rheumatoid arthritis. Int J Nanomedicine. 2021;16:7977–7994.
   PubMed Web of Science ®Google Scholar
• Chen M, Li MH, Zhang N, et al. Pro-angiogenic effect of exosomal microRNA-103a in mice with rheumatoid arthritis via the downregulation of hepatocyte nuclear factor 4 alpha and activation of the JAK/STAT3 signaling pathway. J Biol Regul Homeost Agents. 2021;35(2):629–640.
   PubMed Web of Science ®Google Scholar
• Zisman D, Safieh M, Simanovich E, et al. Tocilizumab (TCZ) decreases angiogenesis in rheumatoid arthritis through its regulatory effect on miR-146a-5p and EMMPRIN/CD147. Front Immunol. 2021;12:739592. doi:10.3389/fimmu.2021.739592.
   PubMed Web of Science ®Google Scholar
• Sun W, Ma J, Zhao H, et al. Resolvin D1 suppresses pannus formation via decreasing connective tissue growth factor caused by upregulation of miRNA-146a-5p in rheumatoid arthritis. Arthritis Res Ther. 2020;22(1):61. doi:10.1186/s13075-020-2133-2.
   PubMed Web of Science ®Google Scholar
• Yang Z, Chen J, Xie H, et al. Androgen receptor suppresses prostate cancer metastasis but promotes bladder cancer metastasis via differentially altering miRNA525-5p/SLPI-mediated vasculogenic mimicry formation. Cancer Lett. 2020;473:118–129. doi:10.1016/j.canlet.2019.12.018.
   PubMed Web of Science ®Google Scholar
• Xie P, Han Q, Liu D, et al. miR-525-5p modulates proliferation and epithelial–mesenchymal transition of glioma by targeting Stat-1. Onco Targets Ther. 2020;13:9957–9966. doi:10.2147/OTT.S257951.
   PubMedGoogle Scholar
• Chen M, Liu LX. miR-525-5p repressed metastasis and anoikis resistance in cervical cancer via blocking UBE2C/ZEB1/2 signal axis. Dig Dis Sci. 2020;65(8):2442–2451. doi:10.1007/s10620-019-05916-9.
   PubMed Web of Science ®Google Scholar
• Zhang B, Jin Z, Zhang H. LINC01207 promotes the progression of non-small cell lung cancer via regulating ARHGAP11A by sponging miR-525-5p. Cancer Biomark. 2022;33(3):401–414. doi:10.3233/CBM-203197.
   PubMed Web of Science ®Google Scholar
• Lip SV, Boekschoten MV, Hooiveld GJ, et al. Early-onset preeclampsia, plasma microRNAs, and endothelial cell function. Am J Obstet Gynecol. 2020;222(5):497.e1–497.e12. doi:10.1016/j.ajog.2019.11.1286.
   PubMed Web of Science ®Google Scholar
• Chistiakov DA, Orekhov AN, Bobryshev YV. The role of miR-126 in embryonic angiogenesis, adult vascular homeostasis, and vascular repair and its alterations in atherosclerotic disease. J Mol Cell Cardiol. 2016;97:47–55. doi:10.1016/j.yjmcc.2016.05.007.
   PubMed Web of Science ®Google Scholar
• Gao J, Kong R, Zhou X, et al. miRNA-126 expression inhibits IL-23R mediated TNF-α or IFN-γ production in fibroblast-like synoviocytes in a mice model of collagen-induced rheumatoid arthritis. Apoptosis. 2019;24(3–4):382–615. doi:10.1007/s10495-018-1474-7.
   PubMed Web of Science ®Google Scholar
• Gao J, Zhou XL, Kong RN, et al. microRNA-126 targeting PIK3R2 promotes rheumatoid arthritis synovial fibroblasts proliferation and resistance to apoptosis by regulating PI3K/AKT pathway. Exp Mol Pathol. 2016;100(1):192–198. doi:10.1016/j.yexmp.2015.12.015.
   PubMed Web of Science ®Google Scholar
• Qu Y, Wu J, Deng JX, et al. microRNA-126 affects rheumatoid arthritis synovial fibroblast proliferation and apoptosis by targeting PIK3R2 and regulating PI3K–AKT signal pathway. Oncotarget. 2016;7(45):74217–74226. doi:10.18632/oncotarget.12487.
   PubMedGoogle Scholar
• Qiu M, Mo L, Li J, et al. Effects of miR-150-5p on the growth and socs1 expression of rheumatoid arthritis synovial fibroblasts. Clin Rheumatol. 2020;39(3):909–917. doi:10.1007/s10067-019-04894-7.
   PubMed Web of Science ®Google Scholar
• Zeng Y, Wei L, Lali MS, et al. miR-150-5p mediates extravillous trophoblast cell migration and angiogenesis functions by regulating VEGF and MMP9. Placenta. 2020;93:94–100. doi:10.1016/j.placenta.2020.02.019.
   PubMed Web of Science ®Google Scholar
• Mazzeo A, Lopatina T, Gai C, et al. Functional analysis of miR-21-3p, miR-30b-5p and miR-150-5p shuttled by extracellular vesicles from diabetic subjects reveals their association with diabetic retinopathy. Exp Eye Res. 2019;184:56–63. doi:10.1016/j.exer.2019.04.015.
   PubMed Web of Science ®Google Scholar
• Vimalraj S, Subramanian R, Dhanasekaran A. LncRNA MALAT1 promotes tumor angiogenesis by regulating microRNA-150-5p/VEGFA signaling in osteosarcoma: in-vitro and in-vivo analyses. Front Oncol. 2021;11:742789. doi:10.3389/fonc.2021.742789.
   PubMed Web of Science ®Google Scholar
• Chen X, Xu X, Pan B, et al. miR-150-5p suppresses tumor progression by targeting VEGFA in colorectal cancer. Aging. 2018;10(11):3421–3437. doi:10.18632/aging.101656.
   PubMedGoogle Scholar
• Wang YH, Kuo SJ, Liu SC, et al. Apelin affects the progression of osteoarthritis by regulating VEGF-dependent angiogenesis and miR-150-5p expression in human synovial fibroblasts. Cells. 2020;9(3):594. doi:10.3390/cells9030594.
   PubMed Web of Science ®Google Scholar
• Zeng H, He D, Xie H, et al. H19 regulates angiogenic capacity of extravillous trophoblasts by H19/miR-106a-5p/VEGFA axis. Arch Gynecol Obstet. 2020;301(3):671–679. doi:10.1007/s00404-020-05469-7.
   PubMed Web of Science ®Google Scholar
• Liang ZH, Pan NF, Lin SS, et al. Exosomes from mmu_circ_0001052-modified adipose-derived stem cells promote angiogenesis of DFU via miR-106a-5p and FGF4/p38MAPK pathway. Stem Cell Res Ther. 2022;13(1):336. doi:10.1186/s13287-022-03015-7.
   PubMed Web of Science ®Google Scholar
• Maisto R, Trotta MC, Petrillo F, et al. Resolvin D1 modulates the intracellular VEGF-related miRNAs of retinal photoreceptors challenged with high glucose. Front Pharmacol. 2020;11:235. doi:10.3389/fphar.2020.00235.
   PubMed Web of Science ®Google Scholar
• Li CW, Zheng J, Deng GQ, et al. Exosomal miR-106a-5p accelerates the progression of nasopharyngeal carcinoma through FBXW7-mediated TRIM24 degradation. Cancer Sci. 2022;113(5):1652–1668. doi:10.1111/cas.15337.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Zhu K, Wang G. miR-106a-5p carried by tumor-derived extracellular vesicles promotes the invasion and metastasis of ovarian cancer by targeting KLF6. Clin Exp Metastasis. 2022;39(4):603–621. doi:10.1007/s10585-022-10165-8.
   PubMed Web of Science ®Google Scholar
• Liu J, Huang Y, Wang H, et al. miR-106a-5p promotes 5-FU resistance and the metastasis of colorectal cancer by targeting TGFβR2. Int J Clin Exp Pathol. 2018;11(12):5622–5634.
   PubMed Web of Science ®Google Scholar
• Pan YJ, Wei LL, Wu XJ, et al. miR-106a-5p inhibits the cell migration and invasion of renal cell carcinoma through targeting PAK5. Cell Death Dis. 2017;8(10):e3155. doi:10.1038/cddis.2017.561.
   PubMedGoogle Scholar
• Zhou Y, Zhang Y, Li Y, et al. microRNA-106a-5p promotes the proliferation, autophagy and migration of lung adenocarcinoma cells by targeting LKB1/AMPK. Exp Ther Med. 2021;22(6):1422. doi:10.3892/etm.2021.10857.
   PubMed Web of Science ®Google Scholar
• Dunaeva M, Blom J, Thurlings R, et al. Circulating serum miR-223-3p and miR-16-5p as possible biomarkers of early rheumatoid arthritis. Clin Exp Immunol. 2018;193(3):376–385. doi:10.1111/cei.13156.
   PubMed Web of Science ®Google Scholar
• Castro-Villegas C, Pérez-Sánchez C, Escudero A, et al. Circulating miRNAs as potential biomarkers of therapy effectiveness in rheumatoid arthritis patients treated with anti-TNFα. Arthritis Res Ther. 2015;17(1):49. doi:10.1186/s13075-015-0555-z.
   PubMedGoogle Scholar
• Chen SS, Tang CH, Chie MJ, et al. Resistin facilitates VEGF-A-dependent angiogenesis by inhibiting miR-16-5p in human chondrosarcoma cells. Cell Death Dis. 2019;10(1):31. doi:10.1038/s41419-018-1241-2.
   PubMedGoogle Scholar
• Krock BL, Skuli N, Simon MC. Hypoxia-induced angiogenesis: good and evil. Genes Cancer. 2011;2(12):1117–1133. doi:10.1177/1947601911423654.
   PubMedGoogle Scholar
• Qu Y, Liu H, Lv X, et al. microRNA-16-5p overexpression suppresses proliferation and invasion as well as triggers apoptosis by targeting VEGFA expression in breast carcinoma. Oncotarget. 2017;8(42):72400–72410. doi:10.18632/oncotarget.20398.
   PubMedGoogle Scholar
• Wang X, Shang Y, Dai S, et al. microRNA-16-5p aggravates myocardial infarction injury by targeting the expression of insulin receptor substrates 1 and mediating myocardial apoptosis and angiogenesis. Curr Neurovasc Res. 2020;17(1):11–17. doi:10.2174/1567202617666191223142743.
   PubMed Web of Science ®Google Scholar
• Sarzi-Puttini P, Salaffi F, Di Franco M, et al. Pain in rheumatoid arthritis: a critical review. Reumatismo. 2014;66(1):18–27. doi:10.4081/reumatismo.2014.760.
   PubMedGoogle Scholar
• Park CC, Morel JC, Amin MA, et al. Evidence of IL-18 as a novel angiogenic mediator. J Immunol. 2001;167(3):1644–1653. doi:10.4049/jimmunol.167.3.1644.
   PubMed Web of Science ®Google Scholar
• Volin MV, Koch AE. Interleukin-18: a mediator of inflammation and angiogenesis in rheumatoid arthritis. J Interferon Cytokine Res. 2011;31(10):745–751. doi:10.1089/jir.2011.0050.
   PubMed Web of Science ®Google Scholar
• Ruth JH, Park CC, Amin MA, et al. Interleukin-18 as an in vivo mediator of monocyte recruitment in rodent models of rheumatoid arthritis. Arthritis Res Ther. 2010;12(3):R118. doi:10.1186/ar3055.
   PubMed Web of Science ®Google Scholar
• Dai SM, Matsuno H, Nakamura H, et al. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis. Arthritis Rheum. 2004;50(2):432–443. doi:10.1002/art.20064.
   PubMedGoogle Scholar
• Yang K, Wang X, Sun Y, et al. miR-590-3p affects the function of adipose-derived stem cells (ADSCs) on the survival of skin flaps by targeting VEGFA. Regen Ther. 2022;21:322–330. doi:10.1016/j.reth.2022.07.010.
   PubMed Web of Science ®Google Scholar
• You LN, Tai QW, Xu L, et al. Exosomal LINC00161 promotes angiogenesis and metastasis via regulating miR-590-3p/ROCK axis in hepatocellular carcinoma. Cancer Gene Ther. 2021;28(6):719–736. doi:10.1038/s41417-020-00269-2.
   PubMed Web of Science ®Google Scholar
• Bao MH, Li GY, Huang XS, et al. Long noncoding RNA LINC00657 acting as a miR-590-3p sponge to facilitate low concentration oxidized low-density lipoprotein-induced angiogenesis. Mol Pharmacol. 2018;93(4):368–375. doi:10.1124/mol.117.110650.
   PubMed Web of Science ®Google Scholar
• Mori S, Tran V, Nishikawa K, et al. A dominant-negative FGF1 Mutant (the R50E Mutant) suppresses tumorigenesis and angiogenesis. PLOS One. 2013;8(2):e57927. doi:10.1371/journal.pone.0057927.
   PubMed Web of Science ®Google Scholar
• Ge X, Gong L. miR-590-3p suppresses hepatocellular carcinoma growth by targeting TEAD1. Tumour Biol. 2017;39(3):1010428317695947. doi:10.1177/1010428317695947.
   Google Scholar
• Wang WT, Qi Q, Zhao P, et al. miR-590-3p is a novel microRNA which suppresses osteosarcoma progression by targeting SOX9. Biomed Pharmacother. 2018;107:1763–1769. doi:10.1016/j.biopha.2018.06.124.
   PubMed Web of Science ®Google Scholar
• Salem M, O'Brien JA, Bernaudo S, et al. miR-590-3p promotes ovarian cancer growth and metastasis via a novel FOXA2-versican pathway. Cancer Res. 2018;78(15):4175–4190. doi:10.1158/0008-5472.CAN-17-3014.
   PubMed Web of Science ®Google Scholar
• Wan Z, Li X, Luo X, et al. The miR-590-3p/CFHR3/STAT3 signaling pathway promotes cell proliferation and metastasis in hepatocellular carcinoma. Aging. 2022;14(14):5783–5799. doi:10.18632/aging.204178.
   PubMedGoogle Scholar
• Salem M, Shan Y, Bernaudo S, et al. miR-590-3p targets cyclin G2 and FOXO3 to promote ovarian cancer cell proliferation, invasion, and spheroid formation. Int J Mol Sci. 2019;20(8):1810.
   PubMed Web of Science ®Google Scholar
• Liang Z, Bian X, Shim H. Downregulation of microRNA-206 promotes invasion and angiogenesis of triple negative breast cancer. Biochem Biophys Res Commun. 2016;477(3):461–466. doi:10.1016/j.bbrc.2016.06.076.
   PubMed Web of Science ®Google Scholar
• Zheng X, Ma YF, Zhang XR, et al. Circ_0056618 promoted cell proliferation, migration and angiogenesis through sponging with miR-206 and upregulating CXCR4 and VEGF-A in colorectal cancer. Eur Rev Med Pharmacol Sci. 2020;24(8):4190–4202.
   PubMed Web of Science ®Google Scholar
• Xu Z, Zhu C, Chen C, et al. CCL19 suppresses angiogenesis through promoting miR-206 and inhibiting Met/ERK/Elk-1/HIF-1α/VEGF-A pathway in colorectal cancer. Cell Death Dis. 2018;9(10):974. doi:10.1038/s41419-018-1010-2.
   PubMedGoogle Scholar
• Xue D, Yang Y, Liu Y, et al. microRNA-206 attenuates the growth and angiogenesis in non-small cell lung cancer cells by blocking the 14-3-3ζ/STAT3/HIF-1α/VEGF signaling. Oncotarget. 2016;7(48):79805–79813. doi:10.18632/oncotarget.12972.
   PubMedGoogle Scholar
• Chen QY, Jiao DM, Wu YQ, et al. miR-206 inhibits HGF-induced epithelial–mesenchymal transition and angiogenesis in non-small cell lung cancer via c-MET/PI3K/AKT/mTOR pathway. Oncotarget. 2016;7(14):18247–18261. doi:10.18632/oncotarget.7570.
   PubMedGoogle Scholar
• Wang S, Ren L, Shen G, et al. The knockdown of malat1 inhibits the proliferation, invasion and migration of hemangioma endothelial cells by regulating miR-206/VEGFA axis. Mol Cell Probes. 2020;51:101540. doi:10.1016/j.mcp.2020.101540.
   PubMed Web of Science ®Google Scholar
• Zhang C, Luo Y, Cao J, et al. Exosomal lncRNA FAM225A accelerates esophageal squamous cell carcinoma progression and angiogenesis via sponging miR-206 to upregulate NETO2 and FOXP1 expression. Cancer Med. 2020;9(22):8600–8611. doi:10.1002/cam4.3463.
   PubMed Web of Science ®Google Scholar
• Law YY, Lee WF, Hsu CJ, et al. miR-let-7c-5p and miR-149-5p inhibit proinflammatory cytokine production in osteoarthritis and rheumatoid arthritis synovial fibroblasts. Aging. 2021;13(13):17227–17236. doi:10.18632/aging.203201.
   PubMedGoogle Scholar
• Wu R, Tang S, Wang Q, et al. Hsa_circ_0003602 contributes to the progression of colorectal cancer by mediating the miR-149-5p/SLC38A1 axis. Gut Liver. 2023;17(2):267–279. doi:10.5009/gnl210542.
   PubMed Web of Science ®Google Scholar
• Liu R, Wang X, Yan Q. The regulatory network of lncRNA DLX6-AS1/miR-149-5p/ERP44 is possibly related to the progression of preeclampsia. Placenta. 2020;93:34–42. doi:10.1016/j.placenta.2020.02.001.
   PubMed Web of Science ®Google Scholar
• Shao Y, Li F, Liu H. Circ-DONSON facilitates the malignant progression of gastric cancer depending on the regulation of miR-149-5p/LDHA axis. Biochem Genet. 2022;60(2):640–655. doi:10.1007/s10528-021-10120-4.
   PubMed Web of Science ®Google Scholar
• Hu C, Bai X, Liu C, et al. Long noncoding RNA XIST participates hypoxia-induced angiogenesis in human brain microvascular endothelial cells through regulating miR-485/SOX7 axis. Am J Transl Res. 2019;11(10):6487–6497.
   PubMed Web of Science ®Google Scholar
• Chen D, Fan J, Li X, et al. Downregulation of miR-485-3p promotes proliferation, migration and invasion in prostate cancer through activation of TGF-β signaling. Histol Histopathol. 2022;37(5):423–430.
   PubMed Web of Science ®Google Scholar
• Wang Q, Liu MJ, Bu J, et al. miR-485-3p regulated by malat1 inhibits osteosarcoma glycolysis and metastasis by directly suppressing c-MET and AKT3/mTOR signalling. Life Sci. 2021;268:118925. doi:10.1016/j.lfs.2020.118925.
   PubMed Web of Science ®Google Scholar
• Lou C, Xiao M, Cheng S, et al. miR-485-3p and miR-485-5p suppress breast cancer cell metastasis by inhibiting PGC-1α expression. Cell Death Dis. 2016;7(3):e2159. doi:10.1038/cddis.2016.27.
   PubMedGoogle Scholar
• Bagheri-Hosseinabadi Z, Mirzaei MR, Hajizadeh MR, et al. Plasma microRNAs (miR-146a, miR-103a, and miR-155) as potential biomarkers for rheumatoid arthritis (RA) and disease activity in Iranian patients. Mediterr J Rheumatol. 2021;32(4):324–330. doi:10.31138/mjr.32.4.324.
   PubMedGoogle Scholar
• Renman E, Brink M, Ärlestig L, et al. Dysregulated microRNA expression in rheumatoid arthritis families—a comparison between rheumatoid arthritis patients, their first-degree relatives, and healthy controls. Clin Rheumatol. 2021;40(6):2387–2394. doi:10.1007/s10067-020-05502-9.
   PubMed Web of Science ®Google Scholar
• Sun Z, Zhang Q, Yuan W, et al. miR-103a-3p promotes tumour glycolysis in colorectal cancer via hippo/YAP1/HIF1A axis. J Exp Clin Cancer Res. 2020;39(1):250. doi:10.1186/s13046-020-01705-9.
   PubMed Web of Science ®Google Scholar
• Zhang P, Zhao Q, Gong K, et al. Downregulation of miR-103a-3p contributes to endothelial progenitor cell dysfunction in deep vein thrombosis through PTEN targeting. Ann Vasc Surg. 2020;64:339–346. doi:10.1016/j.avsg.2019.10.048.
   PubMed Web of Science ®Google Scholar
• Hsu YL, Hung JY, Chang WA, et al. Hypoxic lung-cancer-derived extracellular vesicle microRNA-103a increases the oncogenic effects of macrophages by targeting PTEN. Mol Ther. 2018;26(2):568–581. doi:10.1016/j.ymthe.2017.11.016.
   PubMed Web of Science ®Google Scholar
• Zhong XQ, Yan Q, Chen ZG, et al. Umbilical cord blood-derived exosomes from very preterm infants with bronchopulmonary dysplasia impaired endothelial angiogenesis: roles of exosomal microRNAs. Front Cell Dev Biol. 2021;9:637248. doi:10.3389/fcell.2021.637248.
   PubMed Web of Science ®Google Scholar
• Meng S, Cao J, Zhang X, et al. Downregulation of microRNA-130a contributes to endothelial progenitor cell dysfunction in diabetic patients via its target Runx3. PLOS One. 2013;8(7):e68611. doi:10.1371/journal.pone.0068611.
   PubMed Web of Science ®Google Scholar
• Liu Y, Han Y, Qu H, et al. Correlation of microRNA expression profile with clinical response to tumor necrosis factor inhibitor in treating rheumatoid arthritis patients: a prospective cohort study. J Clin Lab Anal. 2019;33(7):e22953.
   PubMed Web of Science ®Google Scholar
• Chen X, Xie L, Jiang Y, et al. LCK, FOXC1 and hsa-miR-146a-5p as potential immune effector molecules associated with rheumatoid arthritis. Biomarkers. 2023;28(1):130–138. doi:10.1080/1354750X.2022.2150315.
   PubMed Web of Science ®Google Scholar
• Safari F, Damavand E, Rostamian A, et al. Plasma levels of microRNA-146a-5p, microRNA-24-3p, and microRNA125a-5p as potential diagnostic biomarkers for rheumatoid arthritis. Iran J Allergy Asthma Immunol. 2021;20(3):326–337.
   PubMed Web of Science ®Google Scholar
• Ormseth MJ, Solus JF, Vickers KC, et al. Utility of select plasma microRNA for disease and cardiovascular risk assessment in patients with rheumatoid arthritis. J Rheumatol. 2015;42(10):1746–1751. doi:10.3899/jrheum.150232.
   PubMed Web of Science ®Google Scholar
• Anaparti V, Smolik I, Meng X, et al. Whole blood microRNA expression pattern differentiates patients with rheumatoid arthritis, their seropositive first-degree relatives, and healthy unrelated control subjects. Arthritis Res Ther. 2017;19(1):249. doi:10.1186/s13075-017-1459-x.
   PubMedGoogle Scholar
• Singh A, Patro PS, Aggarwal A. microRNA-132, miR-146a, and miR-155 as potential biomarkers of methotrexate response in patients with rheumatoid arthritis. Clin Rheumatol. 2019;38(3):877–884. doi:10.1007/s10067-018-4380-z.
   PubMed Web of Science ®Google Scholar
• Nam JW, Rissland OS, Koppstein D, et al. Global analyses of the effect of different cellular contexts on microRNA targeting. Mol Cell. 2014;53(6):1031–1043. doi:10.1016/j.molcel.2014.02.013.
   PubMed Web of Science ®Google Scholar
• O'Brien J, Hayder H, Zayed Y, et al. Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol. 2018;9:402. doi:10.3389/fendo.2018.00402.
   PubMed Web of Science ®Google Scholar
• Zisoulis DG, Kai ZS, Chang RK, et al. Autoregulation of microRNA biogenesis by let-7 and argonaute. Nature. 2012;486(7404):541–544. doi:10.1038/nature11134.
   PubMed Web of Science ®Google Scholar
• Tang R, Li L, Zhu D, et al. Mouse miRNA-709 directly regulates miRNA-15a/16-1 biogenesis at the posttranscriptional level in the nucleus: evidence for a microRNA hierarchy system. Cell Res. 2012;22(3):504–515. doi:10.1038/cr.2011.137.
   PubMed Web of Science ®Google Scholar
• Forrest AR, Kanamori-Katayama M, Tomaru Y, et al. Induction of microRNAs, miR-155, miR-222, miR-424 and miR-503, promotes monocytic differentiation through combinatorial regulation. Leukemia. 2010;24(2):460–466. doi:10.1038/leu.2009.246.
   PubMed Web of Science ®Google Scholar
• Wang D, Sun X, Wei Y, et al. Nuclear miR-122 directly regulates the biogenesis of cell survival oncomiR miR-21 at the posttranscriptional level. Nucleic Acids Res. 2018;46(4):2012–2029. doi:10.1093/nar/gkx1254.
   PubMed Web of Science ®Google Scholar
• van Rooij E, Quiat D, Johnson BA, et al. A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev Cell. 2009;17(5):662–673. doi:10.1016/j.devcel.2009.10.013.
   PubMed Web of Science ®Google Scholar
• Jia L, Zheng Y, Lyu M, et al. miR-29b upregulates miR-195 by targeting DNMT3B in tongue squamous cell carcinoma. Sci Bull. 2016;61(3):212–219. doi:10.1007/s11434-016-1001-6.
   Web of Science ®Google Scholar
• Yu Y, Nangia-Makker P, Farhana L, et al. miR-21 and miR-145 cooperation in regulation of colon cancer stem cells. Mol Cancer. 2015;14:98. doi:10.1186/s12943-015-0372-7.
   PubMed Web of Science ®Google Scholar
• Wang Y, Bao W, Liu Y, et al. miR-98-5p contributes to cisplatin resistance in epithelial ovarian cancer by suppressing miR-152 biogenesis via targeting Dicer1. Cell Death Dis. 2018;9(5):447. doi:10.1038/s41419-018-0390-7.
   PubMedGoogle Scholar
• Leonov G, Shah K, Yee D, et al. Suppression of AGO2 by miR-132 as a determinant of miRNA-mediated silencing in human primary endothelial cells. Int J Biochem Cell Biol. 2015;69:75–84. doi:10.1016/j.biocel.2015.10.006.
   PubMed Web of Science ®Google Scholar
• Liu ZZ, Tian YF, Wu H, et al. lncRNA H19 promotes glioma angiogenesis through miR-138/HIF-1α/VEGF axis. Neoplasma. 2020;67(1):111–118. doi:10.4149/neo_2019_190121N61.
   PubMed Web of Science ®Google Scholar
• Lin CJ, Lan YM, Ou MQ, et al. Expression of miR-217 and HIF-1α/VEGF pathway in patients with diabetic foot ulcer and its effect on angiogenesis of diabetic foot ulcer rats. J Endocrinol Invest. 2019;42(11):1307–1317. doi:10.1007/s40618-019-01053-2.
   PubMed Web of Science ®Google Scholar
• Li Y, Yan C, Fan J, et al. miR-221-3p targets HIF-1α to inhibit angiogenesis in heart failure. Lab Invest. 2021;101(1):104–115. doi:10.1038/s41374-020-0450-3.
   PubMed Web of Science ®Google Scholar
• Han N, Xu H, Yu N, et al. miR-203a-3p inhibits retinal angiogenesis and alleviates proliferative diabetic retinopathy in oxygen-induced retinopathy (OIR) rat model via targeting VEGFA and HIF-1α. Clin Exp Pharmacol Physiol. 2020;47(1):85–94. doi:10.1111/1440-1681.13163.
   PubMed Web of Science ®Google Scholar
• Gou L, Xue C, Tang X, et al. Inhibition of exo-miR-19a-3p derived from cardiomyocytes promotes angiogenesis and improves heart function in mice with myocardial infarction via targeting HIF-1α. Aging. 2020;12(23):23609–23618. doi:10.18632/aging.103563.
   PubMedGoogle Scholar
• Zhong J, Huang R, Su Z, et al. Downregulation of miR-199a-5p promotes prostate adeno-carcinoma progression through loss of its inhibition of HIF-1α. Oncotarget. 2017;8(48):83523–83538. doi:10.18632/oncotarget.18315.
   PubMedGoogle Scholar
• Wu Z, Cai X, Huang C, et al. miR-497 suppresses angiogenesis in breast carcinoma by targeting HIF-1α. Oncol Rep. 2016;35(3):1696–1702. doi:10.3892/or.2015.4529.
   PubMed Web of Science ®Google Scholar
• Guo Y, Du F, Tan YL, et al. VEGF-mediated angiogenesis in retinopathy of prematurity is co-regulated by miR-17-5p and miR-20a-5p. Biochem Cell Biol. 2021;99(4):414–423. doi:10.1139/bcb-2020-0357.
   PubMedGoogle Scholar
• Yang Y, Liu Y, Li Y, et al. microRNA-15b targets VEGF and inhibits angiogenesis in proliferative diabetic retinopathy. J Clin Endocrinol Metab. 2020;105(11):3404–3415. doi:10.1210/clinem/dgaa538.
   PubMed Web of Science ®Google Scholar
• Lu Y, Qin T, Li J, et al. microRNA-140-5p inhibits invasion and angiogenesis through targeting VEGF-A in breast cancer. Cancer Gene Ther. 2017;24(9):386–392. doi:10.1038/cgt.2017.30.
   PubMed Web of Science ®Google Scholar
• Zhang JR, Zhu RH, Han XP. miR-140-5p inhibits larynx carcinoma invasion and angiogenesis by targeting VEGF-A. Eur Rev Med Pharmacol Sci. 2018;22(18):5994–6001.
   PubMed Web of Science ®Google Scholar
• Liu H, Chen Y, Li Y, et al. Mir‑195 suppresses metastasis and angiogenesis of squamous cell lung cancer by inhibiting the expression of VEGF. Mol Med Rep. 2019;20(3):2625–2632.
   PubMed Web of Science ®Google Scholar
• Hou P, Li H, Yong H, et al. Pinx1 represses renal cancer angiogenesis via the miR-125a-3p/VEGF signaling pathway. Angiogenesis. 2019;22(4):507–519. doi:10.1007/s10456-019-09675-z.
   PubMed Web of Science ®Google Scholar
• Wei L, Sun C, Zhang Y, et al. miR-503-5p inhibits colon cancer tumorigenesis, angiogenesis, and lymphangiogenesis by directly downregulating VEGF-A. Gene Ther. 2022;29(1–2):28–40. doi:10.1038/s41434-020-0167-3.
   PubMed Web of Science ®Google Scholar
• Wu X, Lei J, Zhou B, et al. miR-628-5p inhibits cervical carcinoma proliferation and promotes apoptosis by targeting VEGF. Am J Med Sci. 2021;361(4):499–508. doi:10.1016/j.amjms.2020.11.031.
   PubMed Web of Science ®Google Scholar
• Zhao LN, Wang P, Liu YH, et al. miR-383 inhibits proliferation, migration and angiogenesis of glioma-exposed endothelial cells in vitro via VEGF-mediated FAK and Src signaling pathways. Cell Signal. 2017;30:142–153. doi:10.1016/j.cellsig.2016.09.007.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zhu CD, Yan B, et al. miRNA-directed regulation of VEGF in tilapia under hypoxia condition. Biochem Biophys Res Commun. 2014;454(1):183–188. doi:10.1016/j.bbrc.2014.10.068.
   PubMed Web of Science ®Google Scholar
• Zhou X, Chen J, Xiao Q, et al. microRNA-638 inhibits cell growth and tubule formation by suppressing VEGFA expression in human Ewing sarcoma cells. Biosci Rep. 2018;38(1):BSR20171017.
   PubMedGoogle Scholar
• Cheng J, Chen Y, Zhao P, et al. Downregulation of miRNA-638 promotes angiogenesis and growth of hepatocellular carcinoma by targeting VEGF. Oncotarget. 2016;7(21):30702–30711. doi:10.18632/oncotarget.8930.
   PubMedGoogle Scholar
• Hao Y, Yang J, Yin S, et al. The synergistic regulation of VEGF-mediated angiogenesis through miR-190 and target genes. RNA. 2014;20(8):1328–1336. doi:10.1261/rna.044651.114.
   PubMed Web of Science ®Google Scholar
• Chang SH, Lu YC, Li X, et al. Antagonistic function of the RNA-binding protein HuR and miR-200b in post-transcriptional regulation of vascular endothelial growth factor-A expression and angiogenesis. J Biol Chem. 2013;288(7):4908–4921. doi:10.1074/jbc.M112.423871.
   PubMed Web of Science ®Google Scholar
• Chan YC, Roy S, Khanna S, et al. Downregulation of endothelial microRNA-200b supports cutaneous wound angiogenesis by desilencing GATA binding protein 2 and vascular endothelial growth factor receptor 2. Arterioscler Thromb Vasc Biol. 2012;32(6):1372–1382. doi:10.1161/ATVBAHA.112.248583.
   PubMed Web of Science ®Google Scholar
• Yu S, Hong Q, Wang Y, et al. High concentrations of uric acid inhibit angiogenesis via regulation of the Krüppel-like factor 2-vascular endothelial growth factor-A axis by miR-92a. Circ J. 2015;79(11):2487–2498. doi:10.1253/circj.CJ-15-0283.
   PubMed Web of Science ®Google Scholar
• Jo HN, Kang H, Lee A, et al. Endothelial miR-26a regulates VEGF-Nogo-B receptor-mediated angiogenesis. BMB Rep. 2017;50(7):384–389. doi:10.5483/bmbrep.2017.50.7.085.
   PubMed Web of Science ®Google Scholar
• Shi ZM, Wang J, Yan Z, et al. miR-128 inhibits tumor growth and angiogenesis by targeting p70S6K1. PLOS One. 2012;7(3):e32709. doi:10.1371/journal.pone.0032709.
   PubMed Web of Science ®Google Scholar
• Ghosh A, Dasgupta D, Ghosh A, et al. miRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF AND MMP2. Cell Death Dis. 2017;8(3):e2706. doi:10.1038/cddis.2017.123.
   PubMed Web of Science ®Google Scholar
• Tu Y, Liu L, Zhao D, et al. Overexpression of miRNA-497 inhibits tumor angiogenesis by targeting VEGFR2. Sci Rep. 2015;5:13827. doi:10.1038/srep13827.
   PubMed Web of Science ®Google Scholar
• Krebs M, Solimando AG, Kalogirou C, et al. miR-221-3p regulates VEGFR2 expression in high-risk prostate cancer and represents an escape mechanism from sunitinib in vitro. J Clin Med. 2020;9(3):670.
   PubMed Web of Science ®Google Scholar
• Feng J, Huang T, Huang Q, et al. Pro‑angiogenic microRNA‑296 upregulates vascular endothelial growth factor and downregulates Notch1 following cerebral ischemic injury. Mol Med Rep. 2015;12(6):8141–8147. doi:10.3892/mmr.2015.4436.
   PubMed Web of Science ®Google Scholar
• Liang H, Ge F, Xu Y, et al. miR-153 inhibits the migration and the tube formation of endothelial cells by blocking the paracrine of angiopoietin 1 in breast cancer cells. Angiogenesis. 2018;21(4):849–860. doi:10.1007/s10456-018-9630-9.
   PubMed Web of Science ®Google Scholar
• Behera J, Kumar A, Voor MJ, et al. Exosomal lncRNA-H19 promotes osteogenesis and angiogenesis through mediating Angpt1/Tie2-NO signaling in CBS-heterozygous mice. Theranostics. 2021;11(16):7715–7734. doi:10.7150/thno.58410.
   PubMed Web of Science ®Google Scholar
• Liu Z, Guo N, Zhang XJ. Long noncoding TUG1 promotes angiogenesis of HUVECs in PE via regulating the miR-29a-3p/VEGFA and Ang2/Tie2 pathways. Microvasc Res. 2022;139:104231. doi:10.1016/j.mvr.2021.104231.
   PubMed Web of Science ®Google Scholar
• Tang S, Wang D, Zhang Q, et al. miR-218 suppresses gastric cancer cell proliferation and invasion via regulation of angiopoietin-2. Exp Ther Med. 2016;12(6):3837–3842. doi:10.3892/etm.2016.3893.
   PubMed Web of Science ®Google Scholar
• Besnier M, Shantikumar S, Anwar M, et al. miR-15a/-16 inhibit angiogenesis by targeting the Tie2 coding sequence: therapeutic potential of a miR-15a/16 decoy system in limb ischemia. Mol Ther Nucleic Acids. 2019;17:49–62. doi:10.1016/j.omtn.2019.05.002.
   PubMedGoogle Scholar
• Yang C, Lv K, Chen B, et al. miR144-3p inhibits PMVECs excessive proliferation in angiogenesis of hepatopulmonary syndrome via Tie2. Exp Cell Res. 2018;365(1):24–32. doi:10.1016/j.yexcr.2018.02.009.
   PubMed Web of Science ®Google Scholar
• Yang L, Yue W, Zhang H, et al. Dual targeting of angipoietin-1 and von Willebrand factor by microRNA-671-5p attenuates liver angiogenesis and fibrosis. Hepatol Commun. 2022;6(6):1425–1442. doi:10.1002/hep4.1888.
   PubMed Web of Science ®Google Scholar
• Lu Z, Zhang W, Gao S, et al. miR-506 suppresses liver cancer angiogenesis through targeting sphingosine kinase 1 (SPHK1) mRNA. Biochem Biophys Res Commun. 2015;468(1–2):8–13. doi:10.1016/j.bbrc.2015.11.008.
   PubMed Web of Science ®Google Scholar
• Liu Y, Yang Q, Fu H, et al. Müller glia-derived exosomal miR-9-3p promotes angiogenesis by restricting sphingosine-1-phosphate receptor S1P(1) in diabetic retinopathy. Mol Ther Nucleic Acids. 2022;27:491–504. doi:10.1016/j.omtn.2021.12.019.
   PubMedGoogle Scholar
• Xue LX, Shu LY, Wang HM, et al. miR-181b promotes angiogenesis and neurological function recovery after ischemic stroke. Neural Regen Res. 2023;18(9):1983–1989.
   PubMed Web of Science ®Google Scholar
• Fernandes H, Zonnari A, Abreu R, et al. Extracellular vesicles enriched with an endothelial cell pro-survival microRNA affects skin tissue regeneration. Mol Ther Nucleic Acids. 2022;28:307–327. doi:10.1016/j.omtn.2022.03.018.
   PubMedGoogle Scholar
• Zhang P, Yang X, Wang L, et al. Overexpressing miR‑335 inhibits DU145 cell proliferation by targeting early growth response 3 in prostate cancer. Int J Oncol. 2019;54(6):1981–1994. doi:10.3892/ijo.2019.4778.
   PubMed Web of Science ®Google Scholar
• Hua S, Dias TH. Hypoxia-inducible factor (HIF) as a target for novel therapies in rheumatoid arthritis. Front Pharmacol. 2016;7:184. doi:10.3389/fphar.2016.00184.
   PubMed Web of Science ®Google Scholar
• Park SY, Lee SW, Kim HY, et al. Hmgb1 induces angiogenesis in rheumatoid arthritis via HIF-1α activation. Eur J Immunol. 2015;45(4):1216–1227. doi:10.1002/eji.201444908.
   PubMed Web of Science ®Google Scholar
• Westra J, Molema G, Kallenberg CG. Hypoxia-inducible factor-1 as regulator of angiogenesis in rheumatoid arthritis – therapeutic implications. Curr Med Chem. 2010;17(3):254–263. doi:10.2174/092986710790149783.
   PubMed Web of Science ®Google Scholar
• Veale DJ, Orr C, Fearon U. Cellular and molecular perspectives in rheumatoid arthritis. Semin Immunopathol. 2017;39(4):343–354. doi:10.1007/s00281-017-0633-1.
   PubMed Web of Science ®Google Scholar
• Teichert-Kuliszewska K, Maisonpierre PC, Jones N, et al. Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2. Cardiovasc Res. 2001;49(3):659–670. doi:10.1016/s0008-6363(00)00231-5.
   PubMed Web of Science ®Google Scholar
• Kim I, Kim JH, Moon SO, et al. Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Oncogene. 2000;19(39):4549–4552. doi:10.1038/sj.onc.1203800.
   PubMed Web of Science ®Google Scholar
• Sun M, Deng R, Wang Y, et al. Sphingosine kinase 1/sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 pathway: a novel target of geniposide to inhibit angiogenesis. Life Sci. 2020;256:117988. doi:10.1016/j.lfs.2020.117988.
   PubMed Web of Science ®Google Scholar
• Bu Y, Wu H, Deng R, et al. The anti-angiogenesis mechanism of geniposide on rheumatoid arthritis is related to the regulation of PTEN. Inflammopharmacology. 2022;30(3):1047–1062. doi:10.1007/s10787-022-00975-3.
   PubMed Web of Science ®Google Scholar
• Choi C, Jeong W, Ghang B, et al. Cyr61 synthesis is induced by interleukin-6 and promotes migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res Ther. 2020;22(1):275. doi:10.1186/s13075-020-02369-8.
   PubMed Web of Science ®Google Scholar
• Mollaei H, Safaralizadeh R, Rostami Z. microRNA replacement therapy in cancer. J Cell Physiol. 2019;234(8):12369–12384. doi:10.1002/jcp.28058.
   PubMed Web of Science ®Google Scholar
• Tiwari A, Mukherjee B, Dixit M. microRNA key to angiogenesis regulation: miRNA biology and therapy. Curr Cancer Drug Targets. 2018;18(3):266–277. doi:10.2174/1568009617666170630142725.
   PubMed Web of Science ®Google Scholar
• Ganju A, Khan S, Hafeez BB, et al. miRNA nanotherapeutics for cancer. Drug Discov Today. 2017;22(2):424–432. doi:10.1016/j.drudis.2016.10.014.
   PubMed Web of Science ®Google Scholar
• Lee S, Paoletti C, Campisi M, et al. microRNA delivery through nanoparticles. J Control Release. 2019;313:80–95. doi:10.1016/j.jconrel.2019.10.007.
   PubMed Web of Science ®Google Scholar
• Yan Y, Liu XY, Lu A, et al. Non-viral vectors for RNA delivery. J Control Release. 2022;342:241–279. doi:10.1016/j.jconrel.2022.01.008.
   PubMed Web of Science ®Google Scholar
• Seok H, Lee H, Jang ES, et al. Evaluation and control of miRNA-like off-target repression for RNA interference. Cell Mol Life Sci. 2018;75(5):797–814. doi:10.1007/s00018-017-2656-0.
   PubMed Web of Science ®Google Scholar
• Medley JC, Panzade G, Zinovyeva AY. microRNA strand selection: unwinding the rules. Wiley Interdiscip Rev RNA. 2021;12(3):e1627.
   PubMed Web of Science ®Google Scholar
• Wu SY, Yang X, Gharpure KM, et al. 2′-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity. Nat Commun. 2014;5:3459. doi:10.1038/ncomms4459.
   PubMed Web of Science ®Google Scholar
• Mook OR, Baas F, de Wissel MB, et al. Evaluation of locked nucleic acid-modified small interfering RNA in vitro and in vivo. Mol Cancer Ther. 2007;6(3):833–843. doi:10.1158/1535-7163.MCT-06-0195.
   PubMed Web of Science ®Google Scholar
• Keskin S, Brouwers CC, Sogorb-Gonzalez M, et al. AAV5-miHTT lowers Huntingtin mRNA and protein without off-target effects in patient-derived neuronal cultures and astrocytes. Mol Ther Methods Clin Dev. 2019;15:275–284. doi:10.1016/j.omtm.2019.09.010.
   PubMed Web of Science ®Google Scholar
• Zafar A, Wang W, Liu G, et al. Molecular targeting therapies for neuroblastoma: progress and challenges. Med Res Rev. 2021;41(2):961–1021. doi:10.1002/med.21750.
   PubMed Web of Science ®Google Scholar
• Challagundla KB, Wise PM, Neviani P, et al. Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy. J Natl Cancer Inst. 2015;107(7):djv135.
   PubMedGoogle Scholar
• Berindan-Neagoe I, Calin GA. Molecular pathways: microRNAs, cancer cells, and microenvironment. Clin Cancer Res. 2014;20(24):6247–6253. doi:10.1158/1078-0432.CCR-13-2500.
   PubMed Web of Science ®Google Scholar
• Thone MN, Kwon YJ. Extracellular blebs: artificially-induced extracellular vesicles for facile production and clinical translation. Methods. 2020;177:135–145. doi:10.1016/j.ymeth.2019.11.007.
   PubMed Web of Science ®Google Scholar
• Li D, Wu M. Pattern recognition receptors in health and diseases. Signal Transduct Target Ther. 2021;6(1):291.
   PubMed Web of Science ®Google Scholar
• Lee Y, Urban JH, Xu L, et al. 2′Fluoro modification differentially modulates the ability of RNAs to activate pattern recognition receptors. Nucleic Acid Ther. 2016;26(3):173–182. doi:10.1089/nat.2015.0575.
   PubMed Web of Science ®Google Scholar
• Hamm S, Latz E, Hangel D, et al. Alternating 2′-O-ribose methylation is a universal approach for generating non-stimulatory siRNA by acting as TLR7 antagonist. Immunobiology. 2010;215(7):559–569. doi:10.1016/j.imbio.2009.09.003.
   PubMed Web of Science ®Google Scholar
• Artegiani B, Clevers H. Use and application of 3D-organoid technology. Hum Mol Genet. 2018;27(R2):R99–R107. doi:10.1093/hmg/ddy187.
   PubMed Web of Science ®Google Scholar
• Aparicio S, Hidalgo M, Kung AL. Examining the utility of patient-derived xenograft mouse models. Nat Rev Cancer. 2015;15(5):311–316. doi:10.1038/nrc3944.
   PubMed Web of Science ®Google Scholar
• Cheng P, Wang J. The potential of circulating microRNA-125a and microRNA-125b as markers for inflammation and clinical response to infliximab in rheumatoid arthritis patients. J Clin Lab Anal. 2020;34(8):e23329.
   PubMed Web of Science ®Google Scholar
• Hong H, Yang H, Xia Y. Circulating miR-10a as predictor of therapy response in rheumatoid arthritis patients treated with methotrexate. Curr Pharm Biotechnol. 2018;19(1):79–86. doi:10.2174/1389201019666180417155140.
   PubMed Web of Science ®Google Scholar
• Li N, Chen Z, Feng W, et al. Triptolide improves chondrocyte proliferation and secretion via down-regulation of miR-221 in synovial cell exosomes. Phytomedicine. 2022;107:154479. doi:10.1016/j.phymed.2022.154479.
   PubMed Web of Science ®Google Scholar
• Hao F, Lee RJ, Zhong L, et al. Hybrid micelles containing methotrexate-conjugated polymer and co-loaded with microRNA-124 for rheumatoid arthritis therapy. Theranostics. 2019;9(18):5282–5297. doi:10.7150/thno.32268.
   PubMed Web of Science ®Google Scholar
• Wang M, Mei L, Liu Z, et al. The mechanism of Chinese herbal formula HQT in the treatment of rheumatoid arthritis is related to its regulation of lncRNA uc.477 and miR-19b. J Leukoc Biol. 2020;108(2):519–529. doi:10.1002/JLB.3MA0620-441RRRR.
   PubMed Web of Science ®Google Scholar
• Xiao J, Cai X, Zhou W, et al. Curcumin relieved the rheumatoid arthritis progression via modulating the linc00052/miR-126-5p/PIAS2 axis. Bioengineered. 2022;13(4):10973–10983. doi:10.1080/21655979.2022.2066760.
   PubMed Web of Science ®Google Scholar
• Zhao X, Yi Y, Jiang C, et al. Gancao Fuzi decoction regulates the Th17/Treg cell imbalance in rheumatoid arthritis by targeting Foxp3 via miR-34a. J Ethnopharmacol. 2023;301:115837. doi:10.1016/j.jep.2022.115837.
   PubMed Web of Science ®Google Scholar
• Meng D, Li J, Li H, et al. Salvianolic acid B remits LPS-induced injury by up-regulating miR-142-3p in MH7A cells. Biomed Pharmacother. 2019;115:108876. doi:10.1016/j.biopha.2019.108876.
   PubMed Web of Science ®Google Scholar
• Wu ZM, Luo J, Shi XD, et al. Icariin alleviates rheumatoid arthritis via regulating miR-223-3p/NLRP3 signalling axis. Autoimmunity. 2020;53(8):450–458. doi:10.1080/08916934.2020.1836488.
   PubMed Web of Science ®Google Scholar
• Zhao C, Li XY, Li ZY, et al. Moxibustion regulates T-regulatory/T-helper 17 cell balance by modulating the microRNA-221/suppressor of cytokine signaling 3 axis in a mouse model of rheumatoid arthritis. J Integr Med. 2022;20(5):453–462. doi:10.1016/j.joim.2022.06.002.
   PubMedGoogle Scholar